As of 2025-07-08, the Intrinsic Value of Apex Medical Corp (4106.TW) is 30.53 TWD. This 4106.TW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 22.20 TWD, the upside of Apex Medical Corp is 37.50%.
The range of the Intrinsic Value is 20.15 - 92.61 TWD
Based on its market price of 22.20 TWD and our intrinsic valuation, Apex Medical Corp (4106.TW) is undervalued by 37.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 20.15 - 92.61 | 30.53 | 37.5% |
| DCF (Growth 10y) | 20.14 - 83.32 | 29.28 | 31.9% |
| DCF (EBITDA 5y) | 16.26 - 19.24 | 17.85 | -19.6% |
| DCF (EBITDA 10y) | 17.82 - 22.01 | 19.90 | -10.3% |
| Fair Value | 8.69 - 8.69 | 8.69 | -60.84% |
| P/E | 11.79 - 19.53 | 15.60 | -29.7% |
| EV/EBITDA | 14.04 - 22.31 | 19.40 | -12.6% |
| EPV | 27.22 - 39.22 | 33.22 | 49.6% |
| DDM - Stable | 11.64 - 77.89 | 44.77 | 101.7% |
| DDM - Multi | 12.97 - 69.03 | 22.00 | -0.9% |
| Market Cap (mil) | 2,240.20 |
| Beta | 0.76 |
| Outstanding shares (mil) | 100.91 |
| Enterprise Value (mil) | 1,920.14 |
| Market risk premium | 5.98% |
| Cost of Equity | 6.49% |
| Cost of Debt | 4.25% |
| WACC | 6.11% |